Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Laboratory Investigation

• Publication date

  2017-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1038/labinvest.2016.135PMID 27941755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EMT: 2016.

  2016cited by this paper
• Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.

  2016cited by this paper
• Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype

  2016cited by this paper
• Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)

  2015cited by this paper
• Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture

  2015cited by this paper
• Epithelial-mesenchymal interactions in fibrosis and repair. Transforming growth factor-β activation by epithelial cells and fibroblasts.

  2015cited by this paper
• Cellular interactions in the pathogenesis of interstitial lung diseases

  2015cited by this paper
• Idiopathic pulmonary fibrosis.

  2014influential reference
• EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis

  2014cited by this paper
• The epithelium in idiopathic pulmonary fibrosis: breaking the barrier

  2014influential reference
• The epigenetics of epithelial-mesenchymal plasticity in cancer

  2013cited by this paper
• Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells

  2013cited by this paper
• Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side

  2013cited by this paper
• BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer

  2013cited by this paper
• NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.

  2013cited by this paper
• Histology for Pathologists

  2012cited by this paper
• Idiopathic pulmonary fibrosis

  2011cited by this paper
• Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

  2011cited by this paper
• Keratins in health and cancer: more than mere epithelial cell markers

  2011cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

  2011cited by this paper
• TGFβ signalling: a complex web in cancer progression

  2010cited by this paper
• The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices.

  2009cited by this paper
• Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors

  2009cited by this paper
• Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.

  2008cited by this paper
• Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

  2008cited by this paper
• Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases.

  2008cited by this paper
• Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

  2006cited by this paper
• Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.

  2005cited by this paper
• Architecture of the Lung: Morphology and Function

  2004cited by this paper
• Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.

  2004cited by this paper
• Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.

  2004cited by this paper
• Involvement of Napsin A in the C- and N-terminal Processing of Surfactant Protein B in Type-II Pneumocytes of the Human Lung*

  2003cited by this paper
• Expression of intermediate filament proteins in fetal and adult human lung tissues.

  1989cited by this paper

• PDE4 inhibitor DC591017 ameliorates pulmonary fibrosis through modulating fibroblasts-epithelial cells-alternatively activated macrophages crosstalk.

  2026cites this paper
• Epithelial–mesenchymal transition in pulmonary fibrosis: molecular mechanisms and emerging therapeutic strategies

  2025cites this paper
• An orally bioavailable BRD4 inhibitor disrupts expansion of a pathogenic epithelial-mesenchymal niche in bleomycin-induced fibrosis

  2025cites this paper
• Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities

  2025cites this paper
• Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model

  2025cites this paper
• Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium

  2025cites this paper
• The role of epigenetic regulation in idiopathic pulmonary fibrosis.

  2025cites this paper
• The MUC5B promoter variant results in proteomic changes in the nonfibrotic lung

  2025cites this paper
• Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis

  2024cites this paper
• Epigenetic Regulation of EMP/EMT-Dependent Fibrosis

  2024cites this paper
• The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis

  2024cites this paper
• The Role of Activated Stromal Cells in Fibrotic Foci Formation and Reversion

  2024cites this paper
• Up-regulation by overexpression of c-MET in fibroblastic foci of usual interstitial pneumonia

  2023influential citation
• The potential anti-inflammatory and anti-apoptotic influence of hydrogen sulfide on xenoestrogen induced-toxicity in rats

  2023cites this paper
• Lysyl Oxidase Like 2 (LOXL2) in fibrosis and cardiovascular disease.

  2023cites this paper
• Developing Fibrous Biomaterials to Modulate Epithelial-to-Mesenchymal Transition

  2023cites this paper
• Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis

  2023cites this paper
• Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries

  2023cites this paper
• A prognostic model based on clusters of molecules related to epithelial–mesenchymal transition for idiopathic pulmonary fibrosis

  2023cites this paper
• UIP ako histologický vzor intersticiálneho pľúcneho postihnutia

  2023cites this paper
• In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis

  2023cites this paper
• Physiopathological Mechanisms Involved in the Progression of Pulmonary Fibrosis: A Systematic Review

  2022cites this paper
• Iron-Dependent Mitochondrial Dysfunction Contributes to the Pathogenesis of Pulmonary Fibrosis

  2022cites this paper
• Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies

  2022cites this paper
• Hydrogen sulfide attenuates lung injury instigated by Bisphenol-A via suppressing inflammation and oxidative stress

  2022cites this paper
• IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice

  2022cites this paper
• Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis

  2022cites this paper
• Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches

  2022cites this paper
• Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia

  2022cites this paper
• Bronchial epithelium epithelial-mesenchymal plasticity forms aberrant basaloid-like cells in vitro.

  2022cites this paper
• Regulation of the IGF1 signaling pathway is involved in idiopathic pulmonary fibrosis induced by alveolar epithelial cell senescence and core fucosylation

  2021cites this paper
• Myeloid-mediated IL-1R signaling in immuno-responsive Thy-1 negative fibroblasts is critical for pulmonary fibrosis

  2021cites this paper
• Epithelial Barrier Dysfunction in Chronic Respiratory Diseases

  2021cites this paper
• LncRNA‐ATB regulates epithelial‐mesenchymal transition progression in pulmonary fibrosis via sponging miR‐29b‐2‐5p and miR‐34c‐3p

  2021cites this paper
• Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM

  2021cites this paper
• Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis

  2021cites this paper
• Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices

  2021cites this paper
• Cell tracing reveals the transdifferentiation fate of mouse lung epithelial cells during pulmonary fibrosis in vivo

  2021cites this paper
• IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in RA-ILD through mTOR/S6 signaling.

  2021cites this paper
• The Role of Interaction between Mitochondria and the Extracellular Matrix in the Development of Idiopathic Pulmonary Fibrosis

  2021cites this paper
• PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis

  2021cites this paper
• LncRNA- ATB regulates epithelial- mesenchymal transition progression in pulmonary fibrosis via sponging miR- 29b- 2- 5p and miR- 34c- 3p

  2021cites this paper
• Epithelial mesenchymal transition in respiratory disease. Fact or fiction.

  2020cites this paper
• Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway

  2020cites this paper
• Pericyte-myofibroblast transition in the human lung.

  2020cites this paper
• DDDT_A_264715 4593..4603

  2020influential citation
• A pre‐investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis

  2020cites this paper
• Bioengineered in Vitro Tissue Model of Fibroblast Activation for Modeling Pulmonary Fibrosis.

  2019cites this paper
• Tissue remodelling in pulmonary fibrosis linked to 5-HT2 receptor activation

  2019cites this paper
• Immunohistochemistry and Molecular Biology in Transbronchial Cryobiopsies

  2019cites this paper
• Gas6 Prevents Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells via Production of PGE2, PGD2 and Their Receptors

  2019cites this paper
• MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.

  2019cites this paper
• Transbronchial cryobiopsy in diffuse parenchymal lung disease

  2019cites this paper
• Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells.

  2019cites this paper
• Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis

  2019cites this paper
• Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury

  2018cites this paper
• Exercise training ameliorates bleomycin‐induced epithelial mesenchymal transition and lung fibrosis through restoration of H2S synthesis

  2018cites this paper
• Trametinib downregulates survivin expression in RB1-positive KRAS-mutant lung adenocarcinoma cells.

  2018cites this paper
• Posttranscriptional control of airway inflammation

  2018cites this paper
• Survivin knockdown induces senescence in TTF-1-expressing, KRAS-mutant lung adenocarcinomas

  2018cites this paper
• Long non-coding RNA-ATB promotes EMT during silica-induced pulmonary fibrosis by competitively binding miR-200c.

  2018cites this paper
• Preclinical Study of Lung Spheroid Cell Therapy in Rodent Models of Pulmonary Fibrosis.

  2018cites this paper
• The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells

  2018cites this paper
• Characterization of distal airway stem‐like cells expressing N‐terminally truncated p63 and thyroid transcription factor‐1 in the human lung

  2018cites this paper
• The CDR1as/miR-7/TGFBR2 Axis Modulates EMT in Silica-Induced Pulmonary Fibrosis

  2018cites this paper
• PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma

  2018cites this paper
• Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis

  2017influential citation
• Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma

  2017influential citation
• Biopsy in idiopathic pulmonary fibrosis: back to the future

  2017cites this paper
• Epithelial mesenchymal transition ( EMT ) , a spectrum of states : role in lung development , homeostasis and disease

  2017cites this paper
• Epithelial‐to‐mesenchymal transition and its role in EGFR‐mutant lung adenocarcinoma and idiopathic pulmonary fibrosis

  2017cites this paper